PRJNA1006804 - Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris (PAUSE) - OmicsDI

Genomics

Dataset Information

Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris (PAUSE)

ABSTRACT: Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris (PAUSE)

PROVIDER: PRJNA1006804 | ENA |

REPOSITORIES: ENA

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1